v3.26.1
Condensed Statements of Cash Flows - USD ($)
 1 Months Ended 3 Months Ended 12 Months Ended
Dec. 31, 2024
Mar. 31, 2026
Mar. 31, 2025
Dec. 31, 2025
Dec. 31, 2024
Cash flows from operating activities:          
Net loss $ (5,112) $ 1,038,689 $ (54,616) $ 4,244,525  
Adjustments to reconcile net loss to net cash used in operating activities:          
Earnings on marketable securities held in Trust Account (1,457,920) (4,624,457)  
Operating expenses paid via promissory note - related party 25,000 112,848  
Operating costs paid by Sponsor from proceeds     267,836  
Changes in operating assets and liabilities:          
Prepaid insurance 4,791 16,407 (87,359)  
Prepaid expenses and other current assets 321     (20,000)  
Accrued expenses (44,031) 29,616 98,098  
Due to related party     6,326  
Net cash used in operating activities (446,855) (2,183)  
Cash flows from investing activities:          
Cash deposited into Trust Account     (172,500,000)  
Net cash used in investing activities     (172,500,000)  
Cash flows from financing activities:          
Proceeds from sale of Units, net of underwriting discounts paid     167,662,281  
Proceeds from Private Placement Warrants, less issuance costs     5,432,215  
Proceeds from Public Warrants, less issuance costs     468,608  
Net cash provided by financing activities       173,563,104  
Net decrease in cash and cash equivalents (446,855) 1,060,921  
Cash and cash equivalents at beginning of period 1,060,921  
Cash and cash equivalents at end of period 614,066 1,060,921
Supplemental Disclosure of Non-Cash Investing and Financing Activities:          
Deferred offering cost paid by Sponsor in exchange for issuance of Class B ordinary shares (25,000)      
Deferred underwriting fee payable charged to Class A ordinary share issuance costs     6,900,000  
Underwriting fees paid via the issuance of Private Placement Warrants     1,725,000  
Repayment of promissory note - related party via funds held by Sponsor     112,848  
Proceeds from sale of AMB paid through reduction in deposit balances      
Deferred offering costs included in accrued offering costs   88,322    
Deferred offering costs paid via promissory note - related party   87,848    
Operating expenses paid via promissory note - related party   25,000    
Old Glory Holding Co [Member]          
Cash flows from operating activities:          
Net loss   (4,545,000) (4,114,000) (14,842,000) (14,486,000)
Adjustments to reconcile net loss to net cash used in operating activities:          
Depreciation   20,000 16,000 97,000 91,000
Provision for credit losses   196,000 67,000 371,000 18,000
Amortization of core deposit intangible   3,000 3,000 14,000 14,000
Amortization of deferred technology expenses   204,000 285,000 498,000 334,000
Gain on sale of mortgage loans   (117,000) (92,000) (508,000) (961,000)
Gain on sale of investment securities       (132,000)
Proceeds from loan sales   6,057,000 5,535,000 24,802,000 37,390,000
Loans originated for sale   (8,666,000) (4,704,000) (24,155,000) (35,478,000)
Net accretion of securities available for sale   (8,000) (3,000) 14,000 (21,000)
Stock compensation expense   883,000 275,000 1,099,000 687,000
Changes in operating assets and liabilities:          
Net increase in accrued interest   (165,000) (100,000) (329,000) (6,000)
Net increase in other assets   (440,000) (140,000) (620,000) 412,000
Net increase (decrease) in accrued interest and other liabilities   (13,000) 742,000 823,000 (59,000)
Net cash used in operating activities   (6,591,000) (2,230,000) (12,868,000) (12,065,000)
Cash flows from investing activities:          
Net increase in loans   (4,929,000) (6,479,000) (13,917,000) (1,103,000)
Proceeds from sale of AMB loans       509,000
Maturities / paydowns of investment securities available for sale   13,046,000 576,000 5,582,000 450,000
Purchases of investment securities available for sale   (53,243,000) (20,179,000) (177,006,000) (162,000)
Proceeds from sales of securities available for sale       8,532,000
Reduction (increase) in deferred technology expenses   (188,000) (261,000) 33,000 (1,589,000)
Purchases of premises and equipment   (18,000) (3,000) (42,000) (66,000)
Net cash used in investing activities   (45,332,000) (26,346,000) (176,818,000) (1,961,000)
Cash flows from financing activities:          
Net change in non interest bearing deposits   11,083,000 5,450,000 31,849,000 22,206,000
Net change in interest bearing deposits   11,738,000 12,886,000 41,840,000 64,524,000
Capital contributions   2,673,000 5,017,000 13,780,000 13,531,000
Proceeds from exercise of stock options and warrants       10,000 386,000
Net repayments of warehouse line of credit       (1,820,000)
Net cash provided by financing activities   25,494,000 23,353,000 87,479,000 98,827,000
Net decrease in cash and cash equivalents   (26,429,000) (5,223,000) (102,207,000) 84,801,000
Cash and cash equivalents at beginning of period   72,399,000 174,605,000 174,605,000 89,804,000
Cash and cash equivalents at end of period $ 174,605,000 45,971,000 169,382,000 72,399,000 174,605,000
Schedule of Certain Cash Flow Information          
Interest paid   549,000 399,000 1,862,000 1,007,000
Non-Cash Investing Activities  
Supplemental Disclosure of Non-Cash Investing and Financing Activities:          
Proceeds from sale of AMB paid through reduction in deposit balances       $ 688,000
Creation of right of use asset and liability   $ 51